Legal & General Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-57,054
| Closed | -$381K | – | 3393 |
|
2023
Q3 | $381K | Buy |
57,054
+77
| +0.1% | +$514 | ﹤0.01% | 2541 |
|
2023
Q2 | $516K | Buy |
56,977
+25,706
| +82% | +$233K | ﹤0.01% | 2454 |
|
2023
Q1 | $227K | Buy |
31,271
+1,334
| +4% | +$9.7K | ﹤0.01% | 2546 |
|
2022
Q4 | $218K | Buy |
29,937
+1,413
| +5% | +$10.3K | ﹤0.01% | 2578 |
|
2022
Q3 | $221K | Buy |
28,524
+8,203
| +40% | +$63.6K | ﹤0.01% | 2584 |
|
2022
Q2 | $139K | Buy |
20,321
+13,486
| +197% | +$92.2K | ﹤0.01% | 2762 |
|
2022
Q1 | $54K | Hold |
6,835
| – | – | ﹤0.01% | 2993 |
|
2021
Q4 | $38K | Buy |
+6,835
| New | +$38K | ﹤0.01% | 3096 |
|